Martes de Divulgación Científica - 22 de abril de 2025 - Congenital Heart Disease - ANDES-CHD study

Value of the Information & Strength of the Argument

The value of the information is high as it addresses a significant public health issue in Peru and other Andean regions: the lack of adapted screening for CCHD at high altitudes. The study provides novel data on pulse oximetry cutoffs for neonates at high altitudes, which is crucial for early detection and reducing mortality. The argumentation is solid, based on a prospective multicenter design with standardized protocols and follow-up. However, the sample size for CCHD cases is small (15), which limits the statistical power. The speaker clearly explains the methodology and results, but the presentation lacks a detailed discussion of limitations and potential biases. The argumentation would be strengthened by referencing the published study and discussing external validity.

Scientific Rigor, Source Quality, Title Accuracy

The scientific rigor is moderate: the study design is appropriate, but the presentation does not provide references to peer-reviewed publications or external validation. The sources cited are not explicitly mentioned in the video; the description only mentions the study title and the speaker. The title accurately reflects the content, but the video is a presentation, not a formal scientific paper. The adequacy between title and content is good. No comments are provided, so no analysis of public trends is possible.

The title accurately reflects the content: a scientific dissemination talk about the ANDES-CHD study on congenital heart disease detection at different altitudes.

7/10

The presentation describes a prospective multicenter study with a clear methodology, including inclusion criteria, standardized measurement protocol, and follow-up. However, the sample size is limited (517 neonates, 15 with critical congenital heart disease), and the results are presented without detailed statistical analysis or peer-reviewed publication reference. The speaker is a researcher involved in the study, providing firsthand information, but the lack of external validation and potential conflicts of interest (e.g., involvement in the study) slightly reduce the overall reliability.

Markers derived by PSI from the transcript: the creator did not define chapters.

• 00:00Introduction and roadmap of the presentation.
• 01:00Background on congenital heart disease prevalence and mortality in Peru.
• 03:00Explanation of the current AAP screening algorithm for pulse oximetry at sea level.
• 05:00Study objectives and inclusion criteria for the ANDES-CHD study.
• 07:00Description of the measurement protocol and equipment used.
• 09:00Follow-up procedures and data collection details.
• 11:00Development of the first algorithm based on clinical cutoffs for altitudes 2500-3599m and 3600-4500m.
• 13:00Development of the second algorithm based on percentiles and its performance.
• 15:00Conclusions, limitations, and future directions.
• 17:00Q&A session begins.

• ANDES-CHD study — The study is mentioned as the main subject of the presentation, but no specific URL is provided.

• American Academy of Pediatrics algorithm for pulse oximetry screening — The video references the AAP algorithm as the baseline for screening, which is consistent with existing guidelines.

• Potential high false positive rates at altitude — The study itself acknowledges a high false positive rate (27% for the first algorithm), which may be a concern for implementation. This is not necessarily discordant but highlights a limitation.